US Edition
News from newportnewstimes.com
We’ve assigned a media bias rating of unknown to newportnewstimes.com. You can read more about our methodology here.
Information about newportnewstimes.com
Where is newportnewstimes.com located?newportnewstimes.com's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top newportnewstimes.com News
Medical · ChinaBaker McKenzie represented Takeda in its global strategic partnership with Innovent Biologics, bolstering Takeda’s oncology pipeline with next-generation investigational medicines for the treatment of solid tumors. Under terms of the agreement, Takeda will gain rights to two late-stage oncology assets —IBI363 and IBI343—outside Greater China, and an exclusive option to license an early-stage program. IBI363, a bispecific antibody fusion protein,…See the Story
Baker McKenzie Advises Takeda In Global Strategic Partnership With Innovent Biologics.
93% Center coverage: 15 sources
Las Vegas, Nevada · Las VegasLAS VEGAS, Oct. 21, 2025 /PRNewswire/ -- A donor advised fund created by BOXABL founder Paolo Tiramani has distributed BOXABL preferred stock to the Trust for the National Mall valued at $10 million based on the per share price of…See the Story
DAF Funded by Paolo Tiramani, BOXABL Founder, Donates Equities Valued at $10 Million to the National Mall
100% Center coverage: 13 sources
